alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
## Asian PacificAmerican Chamber of Commerce

Peter Wong Chairman Ron Shahani Vice Chairman Suk-KyuKoh President Grace Lee Vice PresidentlTreasurer Peter Schreck Secretary Wallace K. Tsuha, Jr. Chairman Emeritus Directors: B.N. Bahadur Stephanie Beau Amat Berry-Brown Bing Goei Jimmy Hsiao Jamie Hsu, Ph.D. R.I. King Peng-Li Liu Janny Lu ErnestinaMac, M.D. VictorNaidu Dominic Pangborn Brenda Schneider Shigeki Terashi Executive Director Denise Vee Grim 2009 Corporate Sponsors • ·DTE Energy • Nippon Oil • ToyotaMotor Engineering &

ManufacturingNA, Inc. • ComericaBank • Ford MotorCompany • General Motors Company • SaturnElectronics &

Engineering, Inc. • Darden Restaurants • DelphiCorporation • DeltaAirLines • Dow Automotive Systems • Visteon Corporation February 26, 2010 TheHonorable Ray LaHood United States Department ofTransportation 1200 New Jersey Avenue, SE Washington, DC 20590 Dear Secretary LaHood: Oil behalfofAPACC

.. Asian Pacific American Chamber ofCommerce, I am writing to express our strong support for the application ofDeltaAir Lines for new nonstop service between Detroit and Haneda. Approval ofDelta's new service would be a major benefit for our region, where many corporations have strong trade and market presence with Japan. There are over 500 Japanese companies located in Michigan and hundreds more whose business models rely on access to Japan and it's market. The growth ofourbusiness ties with Japan has created demandfor increased capacity to Tokyo. Ourbusiness travelers look to the convenience offlying into Tokyo's downtown Haneda airport. Detroit is aproven and successful gateway to Asia, and as an airportthat can support**trans~pacific** routes. This summer Delta is adding new service to Seoul and Hong Kong, fulfilling the commitment Delta made to Detroit Metro Airport to make it the airlines gateway to Asia. The addition of Haneda as a destination is a natural fit that would clearly benefitour business travelers. APACC's mission is to facilitate business relationships among Asian and U.S. companies and to promote entrepreneurship for the advancement of Asian Pacific Americans. APACC is committed to serve as a catalyst for expanding business opportunities for companies that desire to connect with Asian Pacific American businesses andthe global Asian consumer markets

. Thank you for consideration ofthis request. Sincerely,

Peter Wong, CPA APACC Chairman ofthe Board Cc: Susy Heintz Avery, Wayne County Airport Authority

2120AustinAvenue, RochesterHills, MI48326 Phone (248) 8444100 Fax (248) 844-4280 www.apacc.net
27252

#### State v. Waialae

Vacated and Remanded
Chapter 2.4.4. – Infection with Marteilia refringens

Annex 8. Item 6.4. – Article 1.3.1. of Chapter 1.3. ‘Diseases listed by WOAH’

CHAPTER 1.3.

DISEASES LISTED BY WOAH

[...]

Article 1.3.1.

The following *diseases*of fish are *listed diseases*:

–	Infection with *Aphanomyces invadans*(epizootic ulcerative syndrome)

–	Infection with epizootic haematopoietic necrosis virus

–	Infection with *Gyrodactylus salaris*

–	Infection with HPR-deleted or HPR0 infectious salmon anaemia virus

–	Infection with infectious haematopoietic necrosis virus

–	Infection with**the~~all~~ genogroups of the virus species*infectious spleen and kidney necrosis virus*

–	Infection with koi herpesvirus

–	~~Infection with red sea bream iridovirus~~

–	Infection with salmonid alphavirus

–	Infection with spring viraemia of carp virus

–	Infection with tilapia lake virus

–	Infection with viral haemorrhagic septicaemia virus.

[...]

______________

WOAH *Aquatic Manual* 2025	8
NOT FOR PUBLICATION 1

2

UNITED STATES COURT OF APPEALS 3

4

FOR THE NINTH CIRCUIT 5

6

JOSE LEON GONZALES

- LONGORIA,

AKA Jose Leon Gonzalez

- Longoria,

Petitioner

- Appellant,

v.

DENNIS MATTHEW WONG; et al.,

Respondents

- Appellees. No. 18

- 15777

D.C. No. 1:17

- cv

- 01587

- LJO

- MJS

MEMORANDUM *

7

Appeal from the United States District Court 8

for the Eastern District of California 9

Lawrence J. O’ Neill, Chief Judge, Presiding 10

11

Submitted August 15, 2018 ** 12

13

Before: FARRIS, BYBEE, and N.R. SMITH

, Circuit Judges

. 14

Federal prisoner Jose Leon Gonzales

- Longoria appeals pro se from the 15

district court’s judgment dismissing his petition for writ of mandamus. We have 16

jurisdiction under 28 U.S.C. § 1291. We review de novo. Wilhelm v. Rotman , 680 17

F.3d 111 3, 1118 (9th Cir. 2012) (dismissal under 28 U.S.C. § 1915A); Kildare v. 18

* This disposition is not appropriate for publication and is not precedent

except as provided by Ninth Circuit Rule 36

- 3.

** The panel unanimously concludes this case is suitable for decision

without oral argument. See Fed. R. App. P. 34(a)(2). 

# FILED

AUG 21 2018

MOLLY C. DWYER, CLER K

U.S. COURT OF APPEAL S2

Saenz , 325 F. 3d 1078, 1082 (9th Cir. 2003) (denial of mandamus); Barren v. 1

Harrington , 152 F.3d 1193, 1194 (9th Cir. 1998) (order) (dismiss al under 28 2

U.S.C. § 1915(e)(2)(B)(ii))

. We affirm. 3

The district court properly dismissed Gonzalez

- Longoria’s petition for writ 4

of mandamus because Gonzalez

- Longoria failed to show that there was “no other 5

adequate remedy” available. Lowry v. Barhart

, 329 F.3d 1019, 1021 (9th Cir. 6

2003) (citation and internal quotation marks omitted) (setting forth elements for 7

mandamus relief). 8

AFFIRMED

. 9
Order No. 97-36

19493

April 22, 1997

#### State v. Siga

Affirmed
COURT OF APPEALS FOR THE

FIRST DISTRICT OF TEXAS AT HOUSTON

ORDER ON MOTION

Cause Number: 01-14-00179-CV

Trial Court Cause 

Number: 2012-07156

Style: Victor Kareh M.D.

v. Tracy Windrum, Individually, as Representative of the Estate of Lancer Windrum, and 

on Behalf of her Minor Children B.W., J.W., and H.W.

Date motion filed*: February 2, 2015

Type of motion: Motion for Extension of Time to File Reply Brief

Party filing motion: Appellant

Document to be filed: Reply Brief

Is appeal accelerated? Yes No

If motion to extend time:

Original due date: December 29, 2014

Number of previous extensions granted: 2

Date Requested: February 6, 2015

Ordered that motion is:

 Granted

If document is to be filed, document due: February 6, 2015

Absent extraordinary circumstances, the Court will not grant additional motions to extend time

The Court will not grant additional motions to extend time.

 Denied

 Dismissed (e.g., want of jurisdiction, moot)

 Other: _____________________________________ 

Judge's signature: /s/ Evelyn V. Keyes

 Acting individually Acting for the Court

Date: February 3, 2015
#### In the Matter of D. P., a minor, Appellant, v. STATE of Alaska, Appellee.

No. 2857.

Supreme Court of Alaska.

Dec. 17, 1976.

Christopher R. Cooke, Rice, Hoppner & Hedland, Bethel, for appellant.

Avrum M. Gross, Atty. Gen., Juneau, Joseph D. Balfe, Dist. Atty., Anchorage, and Victor Krumm, Asst. Dist. Atty., Bethel, for appellee.

Before BOOCHEVER, C. J., and RA-BINO WITZ, CONNOR, ERWIN and BURKE, JJ.

OPINION

PER CURIAM.

In this appeal the Attorney General for the State of Alaska has confessed error with regard to the admission of a statement made by the juvenile D. P. The statement in question was admitted into evidence at an adjudicatory hearing to which the minor was a party. The statement was obtained by the police after continued questioning during which the juvenile repeatedly requested that he not be questioned and stated that he did not wish to speak to the police. At the time of the subject questioning the juvenile was alone, i. e., without the presence of a parent, guardian, or attorney.

The Attorney General confesses error based on the cases of *Miranda v. Arizona,*384 U.S. 436, 86 S.Ct. 1602, 16 L.Ed.2d 694 (1966), and *Michigan v. Mosley,*423 U.S. 96, 96 S.Ct. 321, 46 L.Ed.2d 313, 321 (1976).

We have reviewed this case (under the principles announced in *Marks v. State,*496 P.2d 66, 67-68 (Alaska 1972), regarding the receipt of a confession of error by the Attorney General, and find that the confessed error is supported by the record and has legal foundation. Therefore, the findings and judgment dated October 28, 1975, are REVERSED and this case is REMANDED for further proceedings in the superior court. Further, it is ordered that D. P. be immediately released from custody pending further proceedings, if any.
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting.

                    The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning                           ( print page 85647)                        individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.                

*Name of Committee:*                         Center for Scientific Review Special Emphasis Panel; Topics in Epidemiology and Population Sciences.                    

*Date:*                         December 15, 2023.                    

*Time:*                         2:00 p.m. to 6:00 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).                    

*Contact Person:*                         Rebecca I Tinker, MS, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, Bethesda, MD 20817,  (301) 435-0637,                         *tinkerri@csr.nih.gov*.                    

This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle.

(Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893, National Institutes of Health, HHS)

Dated: December 4, 2023. 

David W. Freeman, 

Supervisory Program Analyst, Office of Federal Advisory Committee Policy.

[FR Doc. 2023-26942 Filed 12-7-23; 8:45 am]

BILLING CODE 4140-01-P
<TABLE> <S> <C>

<ARTICLE> 9
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
FINANCIAL STATEMENTS OF FIRST AMERICAN BANK FOR THE YEAR ENDED DECEMBER 31,
1996, AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL
STATEMENTS.
</LEGEND>
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                          DEC-31-1996
<PERIOD-START>                             JAN-01-1996
<PERIOD-END>                               DEC-31-1996
<CASH>                                           8,271
<INT-BEARING-DEPOSITS>                          22,043
<FED-FUNDS-SOLD>                                     0
<TRADING-ASSETS>                                     0
<INVESTMENTS-HELD-FOR-SALE>                          0
<INVESTMENTS-CARRYING>                               0
<INVESTMENTS-MARKET>                            29,248
<LOANS>                                        172,974
<ALLOWANCE>                                      1,689
<TOTAL-ASSETS>                                 223,018
<DEPOSITS>                                     183,423
<SHORT-TERM>                                     2,430
<LIABILITIES-OTHER>                              1,983
<LONG-TERM>                                     12,500
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                            23
<OTHER-SE>                                      22,660
<TOTAL-LIABILITIES-AND-EQUITY>                 223,018
<INTEREST-LOAN>                                 15,950
<INTEREST-INVEST>                                2,064
<INTEREST-OTHER>                                    41
<INTEREST-TOTAL>                                18,055
<INTEREST-DEPOSIT>                               7,255
<INTEREST-EXPENSE>                               7,881
<INTEREST-INCOME-NET>                           10,174
<LOAN-LOSSES>                                      646
<SECURITIES-GAINS>                                 (51)
<EXPENSE-OTHER>                                  2,307
<INCOME-PRETAX>                                  3,543
<INCOME-PRE-EXTRAORDINARY>                           0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                     2,402
<EPS-PRIMARY>                                     1.06
<EPS-DILUTED>                                        0
<YIELD-ACTUAL>                                    9.48
<LOANS-NON>                                      1,369
<LOANS-PAST>                                         0
<LOANS-TROUBLED>                                     0
<LOANS-PROBLEM>                                    232
<ALLOWANCE-OPEN>                                 1,512
<CHARGE-OFFS>                                      550
<RECOVERIES>                                        81
<ALLOWANCE-CLOSE>                                1,689
<ALLOWANCE-DOMESTIC>                             1,689
<ALLOWANCE-FOREIGN>                                  0
<ALLOWANCE-UNALLOCATED>                              0


</TABLE>
EXHIBIT 32.2



GENAERA CORPORATION



CERTIFICATION OF

CHIEF FINANCIAL OFFICER

PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002



In connection with the Quarterly Report of Genaera Corporation (the Company) on Form 10-Q for the period ended June 30, 2004 as
filed with the Securities and Exchange Commission on the date hereof (the Report), I, John A. Skolas, Executive Vice President and Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant
to section 906 of the Sarbanes-Oxley Act of 2002, that:



| | (1) | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and
| | --- | ---------------------------------------------------------------------------------------------------------------------------------



| | (2) | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
| | --- | ----------------------------------------------------------------------------------------------------------------------------------------------------



|                                                    
|----------------------------------------------------
|/s/ John A. Skolas                                  
|John A. Skolas                                      
|Executive Vice President and Chief Financial Officer
|August 2, 2004
<TABLE> <S> <C>


<ARTICLE> 5
<LEGEND>

This schedule  contains summary financial  information  extracted from InfoNow's
Quarterly  report to stockholders for the three months ended March 31, 1999, and
is qualified in its entirety by reference to such financial statements.

</LEGEND>
<MULTIPLIER> 1,000
       
<S>                                          <C>
<PERIOD-TYPE>                                 3-MOS
<FISCAL-YEAR-END>                          DEC-31-1999
<PERIOD-END>                               MAR-31-1999
<CASH>                                            1516
<SECURITIES>                                         0
<RECEIVABLES>                                      477
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                                  2086
<PP&E>                                            1865
<DEPRECIATION>                                    1070
<TOTAL-ASSETS>                                    2919
<CURRENT-LIABILITIES>                             1510
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                             7
<OTHER-SE>                                        1326
<TOTAL-LIABILITY-AND-EQUITY>                      2919
<SALES>                                           1104
<TOTAL-REVENUES>                                  1104
<CGS>                                              590
<TOTAL-COSTS>                                     1213
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                (16)
<INCOME-PRETAX>                                   (82)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                               (82)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                      (82)
<EPS-PRIMARY>                                    (.01)
<EPS-DILUTED>                                    (.01)
        






</TABLE>
IN THE SUPREME COURT OF PENNSYLVANIA

IN RE:

RE S CISSION OF RULE 4003,
AMENDMENT OF RULE
4008 AND AMENDMENT OF THE
COMMENT S TO RULE 400 6 AND 4007
OF THE RULES OF JUDICIAL
ADMINISTRATION :

:

:

:

:

:

:

: NO. 528

JUDICIAL ADMINISTRATION DOCKET

ORDER

PER CURIAM:

AND NOW, this 1 2 th day of December , 20 1 9

, the proposal having been published for public comment at 4 9 Pa.B. 4002 ( August 3 , 201 9 ) , i t is Ordered pursuant to Art icle V, Section 10 of the Constitution of Pennsylvania that Rule 4003 of the Pennsylvania Rules

of Judicial Administration is hereby rescinded, and Rule 4008 and the comment s to Rule

4006 and Rule 4007 are amended in the attached form.

This Order shall be effective immediately and shall be processed in accordance with Rule 103(b) of the Pennsylvania Rules of Judicial Administration.

Justice Dougherty dissents from the dissolution of the Committee o n Court Reporting and Transcripts.

Additions are in bold and underlined.

Deletions are in bold and bracketed.
Item_5_3_12a_Q fever/ page 1

Annex 24

CHAPTER 8.X.INFECTION WITH *COXIELLA**BURNETII* (Q FEVER)

Article 8.X.1.

General provisions

Various animal species and humans can be affected by Q fever. For the purposes of the *Terrestrial Code*, Q fever is defined as an *infection* of domestic and *captive wild* ruminants, ~~dogs, and cats~~and other domestic mammals (hereafter ‘susceptible animal’) with *Coxiella burnetii*. 

**Rationale:** Rabbits, horses and rodents are susceptible to *Coxiella burnetii*.

The following defines the occurrence of *infection* with *C. burnetii*:

1)	*C. burnetii* has been isolated and identified as such in a sample from a susceptible animal; or 

2)	nucleic acid specific to *C. burnetii* has been detected in a sample from a susceptible animal that is epidemiologically linked to a confirmed or suspected *case*; or

3)	antibodies specific to *C. burnetii*, that are not the consequence of *vaccination*, have been detected in a sample from a susceptible animal that is epidemiologically linked to a confirmed or suspected *case*.

Standards for diagnostic tests and vaccines are described in the *Terrestrial Manual*. 

___________________________

*WOAH Terrestrial Animal Health Standards Commission/September 2022*

Report of the Meeting of the WOAH Terrestrial Animal Health Standards Commission / September 2022	1
Order entered October 30, 2015

In The

Court of Appeals 

Fifth District of Texas at Dallas 

No. 05-14-01294-CV

TOM KARTSOTIS, Appellant

V.

RICHARD L. BLOCH, INDIVIDUALLY AND AS A TRUSTEE OF THE RICHARD 

AND NANCY BLOCH FAMILY TRUST, AND NANCY BLOCH AS A TRUSTEE OF 

THE RICHARD AND NANCY BLOCH FAMILY TRUST, Appellees

On Appeal from the 134th Judicial District Court

Dallas County, Texas

Trial Court Cause No. DC-11-04489

ORDER

We GRANT appellant’s October 28, 2015 unopposed motion for an extension of time to 

file his reply brief and cross-appellee’s brief. Appellant shall file his reply brief and crossappellee’s brief by NOVEMBER 19, 2015.

/s/ ELIZABETH LANG-MIERS 

JUSTICE
COURT OF APPEALS FOR THE

FIRST DISTRICT OF TEXAS AT HOUSTON

ORDER

Appellate case name: Pamela Thurman Stallard v. The State of Texas

Appellate case number: 01-18-00451-CR

Trial court case number: 1515996

Trial court: County Criminal Court No. 1 of Tarrant County

Katherine L. Reed, retained counsel for appellant, Pamela Thurman Stallard, has 

filed a “Motion to Withdraw from Representing Appellant and to Substitute Counsel. 

The motion is granted.

The Clerk of this Court is directed to note Katherine L. Reed’s withdrawal as 

counsel for appellant and substitute Emily Taylor for Katherine L. Reed as counsel for 

appellant on the docket of this Court. See TEX. R. APP. P. 6.5(d). 

It is so ORDERED.

Judge’s signature: /s / Terry Jennings

  Acting individually  Acting for the Court

Date: June 26, 2018